Skip to Main Content

Author Details

Stephen J Talks
Newcastle Hospitals NHS Foundation Trust
1993
97
24
PMIDPaper TitleJournal TitlePublished Year
37853106Associations of presenting visual acuity with morphological changes on OCT in neovascular age-related macular degeneration: PRECISE Study Report 2.Eye (Lond)2024
35226581Multiple Evanescent White Dot Syndrome and Choroidal Neovascularization following SARS-COV-2 Infection in a Patient on Dabrafenib and Trametinib.Ocul Immunol Inflamm2023
37109349A Multi-Modal AI-Driven Cohort Selection Tool to Predict Suboptimal Non-Responders to Aflibercept Loading-Phase for Neovascular Age-Related Macular Degeneration: PRECISE Study Report 1.J Clin Med2023
36725098Safety and efficacy of an artificial intelligence-enabled decision tool for treatment decisions in neovascular age-related macular degeneration and an exploration of clinical pathway integration and implementation: protocol for a multi-methods validation study.BMJ Open2023
36626192Stakeholder Perspectives of Clinical Artificial Intelligence Implementation: Systematic Review of Qualitative Evidence.J Med Internet Res2023
36653595Evaluation of standard-of-care intravitreal aflibercept treatment practices in patients with diabetic macular oedema in the UK: DRAKO study outcomes.Eye (Lond)2023
36941402Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomes.Eye (Lond)2023
36525220The Patient Voice in Neovascular Age-Related Macular Degeneration: Findings from a Qualitative Study.Ophthalmol Ther2023
35973593Diabetic Macular Edema and Diode Subthreshold Micropulse Laser: A Randomized Double-Masked Noninferiority Clinical Trial.Ophthalmology2023
33972705Extended real-world experience with the ILUVIEN® (fluocinolone acetonide) implant in the United Kingdom: 3-year results from the Medisoft® audit study.Eye (Lond)2022
35363141Stakeholder Perspectives on Clinical Decision Support Tools to Inform Clinical Artificial Intelligence Implementation: Protocol for a Framework Synthesis for Qualitative Evidence.JMIR Res Protoc2022
36541393Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.Health Technol Assess2022
33911212Utilisation of optical coherence tomography and optical coherence tomography angiography to assess retinal neovascularisation in diabetic retinopathy.Eye (Lond)2022
35314774The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice.Eye (Lond)2022
35087214Action on sickle cell retinopathy: the time is now.Eye (Lond)2022
35301458Retinal vein occlusion (RVO) guideline: executive summary.Eye (Lond)2022
34645965Should we still be performing macular laser for non-centre involving diabetic macular oedema? No.Eye (Lond)2022
34244670Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomes.Eye (Lond)2022
32763265Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration: A Mixed-Methods Systematic Review.Ophthalmology2021
33795837Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations.Eye (Lond)2021
33519189Ten-Year Real-World Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration.Clin Ophthalmol2021
34211264Real-World Anti-Vascular Endothelial Growth Factor Therapy Outcomes in Myopic Choroidal Neovascularization.Clin Ophthalmol2021
33977317Delayed follow-up of medical retina patients due to COVID-19: impact on disease activity and visual acuity.Graefes Arch Clin Exp Ophthalmol2021
34081099Defining Nonadherence and Nonpersistence to Anti-Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular Degeneration.JAMA Ophthalmol2021
33369881A novel tool to assess the quality of RWE to guide the management of retinal disease.Acta Ophthalmol2021
33130553Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence.Br J Ophthalmol2021
32657647Real-World Visual and Neovascularisation Outcomes from anti-VEGF in Central Retinal Vein Occlusion.Ophthalmic Epidemiol2021
31591506The use of optical coherence tomography angiography and optical coherence tomography to predict visual acuity in diabetic retinopathy.Eye (Lond)2020
31844166Management of diabetic macular oedema: new insights and global implications of DRCR protocol V.Eye (Lond)2020
32943833A Comparison of Conventional Intravitreal Injection Method vs InVitria Intravitreal Injection Method.Clin Ophthalmol2020
32712708Macula service evaluation and assessing priorities for anti-VEGF treatment in the light of COVID-19.Graefes Arch Clin Exp Ophthalmol2020
32680477Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems.BMC Ophthalmol2020
30269098United Kingdom Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group: report 4, real-world data on the impact of deprivation on the presentation of diabetic eye disease at hospital services.Br J Ophthalmol2019
31619195Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy - a systematic approach to identify and characterize data sources.BMC Ophthalmol2019
30833667Comment on: Clinical outcomes in Caucasian patients with polypoidal choroidal vasculopathy.Eye (Lond)2019
30797883The use of real-world evidence for evaluating anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration.Surv Ophthalmol2019
30973596Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy.JAMA Ophthalmol2019
30728488Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab.Eye (Lond)2019
30755274Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial.Trials2019
29600987The use of optical coherence tomography angiography for detecting choroidal neovascularization, compared to standard multimodal imaging.Eye (Lond)2018
29867156Intravitreal aflibercept for neovascular age-related macular degeneration in patients aged 90 years or older: 2-year visual acuity outcomes.Eye (Lond)2018
30532519Expanding the role of medical retina virtual clinics using multimodal ultra-widefield and optical coherence tomography imaging.Clin Ophthalmol2018
28168568Purtscher-like retinopathy associated with squamous cell carcinoma of the cervix.Int Ophthalmol2018
28737758Real-world experience with 0.2⿿μg/day fluocinolone acetonide intravitreal implant (ILUVIEN) in the United Kingdom.Eye (Lond)2017
29184385Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update.Clin Ophthalmol2017
28622328Second-year visual acuity outcomes of nAMD patients treated with aflibercept: data analysis from the UK Aflibercept Users Group.Eye (Lond)2017
28905541The Role of New Imaging Methods in Managing Age-Related Macular Degeneration.Asia Pac J Ophthalmol (Phila)2017
28643799Appropriateness of quality standards for meaningful intercentre comparisons of aflibercept service provision for neovascular age-related macular degeneration.Eye (Lond)2017
27080486The incidence of diabetic retinopathy requiring treatment is also low in the under 90 age group.Eye (Lond)2016
26578446First-Year Visual Acuity Outcomes of Providing Aflibercept According to the VIEW Study Protocol for Age-Related Macular Degeneration.Ophthalmology2016
  • 1 - 50 of 97

Recommended Authors

Vaidehi S Dedania
Department of Ophthalmology at NYU Grossman School of Medicine
Career Start Year 2015
Number of shared co-authors 1
Katrin Fasler
University Hospital Zurich, University of Zurich
Career Start Year 2013
Number of shared co-authors 13
Jay Chhablani
University of Pittsburgh
Career Start Year 2008
Number of shared co-authors 11
Kelvin Yi Chong Teo
Singapore Eye Research Institute
Career Start Year 2007
Number of shared co-authors 7
Daniel Barthelmes
University Hospital Zurich and University of Zurich
Career Start Year 2006
Number of shared co-authors 14
Caio V Regatieri
Universidade Federal de Sao Paulo
Career Start Year 2006
Number of shared co-authors 0
Roy Schwartz
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 2006
Number of shared co-authors 21
Katherine E Talcott
Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic
Career Start Year 2005
Number of shared co-authors 2
Lisa C Olmos de Koo
University of Washington
Career Start Year 2005
Number of shared co-authors 3
Yasha S Modi
New York University School of Medicine, New York University Langone Health
Career Start Year 2004
Number of shared co-authors 1
Wen Xing
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 2003
Number of shared co-authors 23
Jayashree Sahni
Novartis Pharma AG
Career Start Year 2001
Number of shared co-authors 10
Rishi P Singh
Cleveland Clinic Martin Hospitals, Cleveland Clinic Florida
Career Start Year 2000
Number of shared co-authors 7
Igor Kozak
Moorfields Eye Hospital Dubai.
Career Start Year 1999
Number of shared co-authors 5
Glenn Yiu
University of California davis
Career Start Year 1998
Number of shared co-authors 1
Manjot K Gill
Feinberg School of Medicine, Northwestern University
Career Start Year 1997
Number of shared co-authors 0
Eric H Souied
University of Paris Est-Creteil
Career Start Year 1994
Number of shared co-authors 14
Judy E Kim
Medical College of Wisconsin
Career Start Year 1994
Number of shared co-authors 5
Allen C Ho
Wills Eye Hospital/Mid Atlantic Retina
Career Start Year 1992
Number of shared co-authors 3
Quan Dong Nguyen
Byers Eye Institute, Stanford University
Career Start Year 1990
Number of shared co-authors 5
Michael W Stewart
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 4
Mark C Gillies
The University of Sydney Save Sight Institute
Career Start Year 1987
Number of shared co-authors 19
Giovanni Staurenghi
Eye Clinic, Department of Biomedical and Clinical Science, University of Milan
Career Start Year 1987
Number of shared co-authors 13
Ian L McAllister
University of Western Australia, Lions Eye Institute
Career Start Year 1987
Number of shared co-authors 9
Jennifer I Lim
University of Illinois at Chicago
Career Start Year 1986
Number of shared co-authors 5
Ronald P Danis
University of Wisconsin, Wisconsin EyeKor Inc.
Career Start Year 1981
Number of shared co-authors 6
Neil M Bressler
Wilmer Eye Institute, Johns Hopkins University School of Medicine
Career Start Year 1979
Number of shared co-authors 9
Maureen G Maguire
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1979
Number of shared co-authors 3
Elias Reichel
Tufts Medical Center
Career Start Year 1975
Number of shared co-authors 1
Stuart L Fine
Kaiser Permanente San Francisco Medical Center
Career Start Year 1965
Number of shared co-authors 0

Collaborators

Sobha Sivaprasad
NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital
Co-authored papers 17
Faruque Ghanchi
Bradford Teaching Hospitals NHS Foundation Trust
Co-authored papers 14
Geeta Menon
Frimley Health NHS Foundation Trust
Co-authored papers 12
Andrew J Lotery
University of Southampton
Co-authored papers 8
Clare Bailey
Bristol Eye Hospital
Co-authored papers 8
Robert P Finger
Universitats-Augenklinik Mannheim
Co-authored papers 8
Tien Yin Wong
Tsinghua University
Co-authored papers 8
Vincent Daien
University Hospital Montpellier
Co-authored papers 7
Louise Downey
Hull and East Yorkshire Hospital, Hull and East Yorkshire NHS Trust
Co-authored papers 6
Richard Gale
Hull York Medical School, University of York
Co-authored papers 6
Andrew C Browning
Royal Victoria Infirmary
Co-authored papers 6
Haralabos Eleftheriadis
Kings College Hospital NHS Foundation Trust
Co-authored papers 5
Robin Hamilton
Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers 5
Sajjad Mahmood
University of Manchester
Co-authored papers 5
Martin McKibbin
Leeds Teaching Hospitals NHS Trust
Co-authored papers 5
Robert L Johnston
Gloucestershire Hospitals NHS Foundation Trust
Co-authored papers 4
Usha Chakravarthy
Queen's University Belfast
Co-authored papers 4
Pearse A Keane
Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers 3
Praveen J Patel
NIHR Moorfields Biomedical Research Centre
Co-authored papers 2
Mali Okada
Royal Victorian Eye and Ear Hospital
Co-authored papers 2
Adnan Tufail
Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers 2
Alastair K Denniston
University Hospitals Birmingham NHS Foundation Trust
Co-authored papers 2
Tunde Peto
Queen's University Belfast
Co-authored papers 2
David P Crabb
University of London
Co-authored papers 1
Rehna Khan
Calderdale and Huddersfield National Health Service Foundation Trust
Co-authored papers 1
Marie D Tsaloumas
Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHSFT
Co-authored papers 1
Maria Pikoula
Institute of Health Informatics, University College London
Co-authored papers 1
Bobby Paul
Havering and Redbridge University Hospitals NHS Trust
Co-authored papers 1
Bhavna J Antony
Monash University
Co-authored papers 1
Peck Lin Lip
Sandwell & West Birmingham NHS Trust
Co-authored papers 1
Release 1.2